Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: Analysis of data from the DRIVE and DESIRABLE studies.
Tsutomu TakeuchiSatoshi SoenNaoki IshiguroHisashi YamanakaSakae TanakaMakiko KobayashiNaoki OkuboTakaya NittaYoshiya TanakaPublished in: Modern rheumatology (2020)
DRIVE, JapicCTI-101263; DESIRABLE, NCT01973569.